According to a new study published by the journal Experimental & Molecular Medicine, cannabinoids may provide a treatment option for neurodegenerative diseases such as Parkinson’s disease.
For the study, researchers at Kyung Hee University, the Korea Institute of Toxicology, Kyungpook National University and Chungbuk National University – all in Korea – used mice who had been injected with a form of Parkinson’s disease. They were treated with a cannabinoid receptor agonist that’s meant to mimic the effects of natural cannabinoids.
“Our results suggest that targeting the cannabinoid system may be beneficial for the treatment of neurodegenerative diseases, such as PD [Parkinson’s disease], that are associated with glial activation, BBB disruption and peripheral immune cell infiltration”
The full study – which was published online by the U.S. National Institute of Health – can be found by clicking here.